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Day to day variability of ventricular ectopic activity was 
analyzed in 45 patients with a history of malignant ventric-
ular tachyarrhythmias who underwent two successive 24 h 
periods of ambulatory electrocardiographic (ECG) moni-
toring in the absence of antiarrhythmic drugs; 26 were male 
and 19 female, with a mean age of 56 years (range 15 to 76). 
The total number of single ventricular premature beats, 
couplets and ventricular tachycardia beats and runs on 
days 1 and 2 demonstrated a consistent overall correlation 
(r = 0.76 to 0.84). Individual variability was evaluated by 
regression analysis with determination of 95% confidence 
limits. 
The minimal decrease in arrhythmia density necessary 
to distinguish true drug effect from spontaneous variability 
was 64% for single ventricular premature beats, 83% for 
couplets, 90% for ventricular tachycardia runs and 93% 
A fundamental difficulty in interpreting biologic data lies in 
their spontaneous variability. This variability may be a 
manifestation of physiologic processes such as feedback 
regulation, circadian rhythmicity or random fluctuations. 
Although much progress has recently been made in under-
standing the electrophysiologic mechanisms of cardiac 
arrhythmias, statistical aspects of arrhythmia variability 
have received comparatively little attention. Previous inves-
tigations 0-4) have defined confidence intervals identifying 
true arrhythmia suppression in popUlations with relatively 
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for ventricular tachycardia beats. To meet the criteria for 
arrhythmia aggravation, the arrhythmia density had to 
increase by 400, 877, 1,500 and 2,400%, respectively. 
Multivariate analysis disclosed an inverse relation between 
day to day arrhythmia variability and baseline arrhythmia 
density and age. Variability was more pronounced in 
patients with coronary artery disease but was not influ-
enced by the type of presenting arrhythmia or left ventric-
ular function. 
The diurnal distribution of arrhythmias and heart rate 
followed a distinct circadian pattern. These data indicate 
that, despite good group reproducibility, spontaneous 
arrhythmia variability in individuals is substantial, neces-
sitating standards to define both drug effect and arrhythmia 
aggravation. 
(J Am Coil CardioI1988;12:656-61) 
benign ventricular arrhythmia, but little information is avail-
able in subjects at risk for sudden death. Indeed, it is 
precisely this population in whom guidelines for determining 
antiarrhythmic drug efficacy need to be defined. Moreover, 
even fewer statistical guidelines are available regarding 
aggravation of arrhythmia (5,6). 
The present study addresses this issue in patients with a 
high density of malignant ventricular tachyarrhythmias and 
develops criteria for antiarrhythmic as well as proarrhythmic 
responses. In addition, the distribution of ventricular 
arrhythmias and heart rate is examined for circadian pat-
terns. 
Methods 
Study patients. The study population comprised 45 pa-
tients with a history of recurrent life-threatening ventricular 
tachyarrhythmias that were refractory to conventional anti-
arrhythmic drugs. As part of an antiarrhythmic drug trial, 
these patients underwent two control 24 h ambulatory elec-
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trocardiographic (ECG) recordings, which form the basis of 
the present investigation. To be eligible, patients had to 
exhibit salvos of ventricular tachycardia (2:3 consecutive 
ventricular premature beats) in at least one of the two 
recordings. Of the 45 patients, 26 were male and 19 female; 
the mean age was 56 years (range 15 to 76). Coronary artery 
disease was diagnosed in 23 patients, cardiomyopathy in 8, 
valvular heart disease in 4 and congenital heart disease in 1. 
In nine individuals, no structural heart disease was found. 
Eight patients presented with a history of ventricular fibril-
lation not secondary to acute myocardial infarction and 37 
with ventricular tachycardia. In 20 of the latter 37 patients, 
ventricular tachycardia was sustained and accompanied by 
syncope whereas the remaining 17 patients had nonsustained 
ventricular tachycardia with hemodynamic compromise. 
Ambulatory electrocardiographic monitoring. Two con-
secutive 24 h Holter ECG recordings were obtained 2:48 h 
after all antiarrhythmic drugs had been discontinued. The 
tapes were analyzed by Cardio Data Systems with the use of 
full disclosure methodology. Stringent quality control pro-
cedures, including blinded insertion of standard tapes with a 
sampling frequency of approximately 2%, were implemented 
to ensure the accuracy and reproducibility of readings. With 
the use of these procedures, the accuracy of high speed 
analysis was 96.6% for total ventricular premature beats, 
91.6% for couplets and 96.7% for ventricular tachycardia 
beats. The reproducibility for these variables among dif-
ferent analysts, or the same analyst at different times, was 
92.6, 94.4 and 99.3%, respectively. The mean recording 
duration was 21.4 ± 3.3 and 21.9 ± 2.1 h, respectively, for 
the first and the second day. 
For each hour, the following data were printed out: low, 
mean and high heart rate; total ventricular premature beats; 
single ventricular premature beats; couplets; ventricular 
tachycardia beats; ventricular tachycardia runs and time 
analyzed. In addition, the percentage of monitoring hours 
containing couplets and ventricular tachycardia was calcu-
lated. 
Analysis of left ventricular function. Left ventricular ejec-
tion fraction was determined by radio nuclide ventriculogra-
phy with the use of the gated equilibrium technique. Global 
ejection fraction was calculated from the time-activity curve 
obtained from 200 to 400 cardiac cycles. In patients with 
frequent ventricular premature beats, data acquisition was 
accomplished with the use of a list mode format in which 
only sinus beats preceded by another sinus beat were 
analyzed (7). 
Statistical analysis. The arrhythmia frequency of each 
hour was normalized to 60 min based on the actual analysis 
time and then totaled to 24 h. To correct for skewed 
distributions and unequal variances, arrhythmia frequencies 
were transformed to their natural logarithm (in [1 + fre-
quency]). Individual day-to-day variability was assessed by 
regression analysis with monitor recording 2 as the depen-
RAEDER ET AL. 657 
SPONTANEOUS ARRHYTHMIA VARIABILITY 
Table 1. Variability of Ventricular Arrhythmias Between Two 
24 h Holter ECG Recordings in 45 Patients 
r Value ± 95% 
Monitor I Monitor 2 Confidence Limits 
Single VPBs' 8,400 9,799 0.84 ± 0.18t 
Couplets' 795 1,111 0.81 ± 0.15t 
VI runs' 32 50 0.80 ± 0.14t 
VI beats' 110 163 0.76 ± O.l1t 
% couplet hours:!: 84 87 0.76 ± O.1lt 
% VI hours:j: 51 52 0.81 ± 0.14t 
'Median; tp < 0.0001; :j:mean. VPBs = ventricular premature beats; VT 
= ventricular tachycardia. 
dent variable (8). Using the upper and lower 95% confidence 
intervals of predicted values, we calculated the minimal 
change in arrhythmia density required to distinguish true 
drug effects from spontaneous variability by: 
. . Day. + CLu Arrhythmia aggravatIOn = ---''-'----''-
Day, x 100 
A . h h . d ffi Day, - CLL nbarr yt mlC rug e ect = , 
Day. x 100 
where CLu = upper 95% confidence limits and, CLL = 
lower 95% confidence limits. 
The independent influence of several clinical variables 
was examined by a stepwise regression procedure where the 
coefficient of variation of the two recordings served as a 
measure of overall variability. In this model, the coefficient 
of variation served as the dependent variable whereas age, 
left ventricular ejection fraction, presenting arrhythmia, sex, 
underlying heart disease, arrhythmia density and heart rate 
were entered as independent variables. To determine 
whether diurnal fluctuations exhibit correlations that could 
be attributed to periodicity, we computed autocorrelograms 
for each Holter recording. The relation of heart rate to 
ventricular ectopic density was examined by cross-
correlation (9). Unless stated otherwise, data are expressed 
as medians and statistical significance is assumed if p < 0.05. 
Results 
Arrhythmia density (Table 1). In the 45 patients, the 
hourly frequency of single ventricular premature beats was 
350 and 408, of couplets 33.1 and 46.3 and of ventricular 
tachycardia episodes 1.3 and 2.1 for the two recordings, 
respectively. There was a distinct diurnal distribution of 
arrhythmia density. At approximately 10 PM, ventricular 
ectopic activity began to subside reaching a trough at 5 AM. 
Between 6 AM and 7 AM, ectopic activity again increased 
peaking between 10 AM and noon. This biphasic behavior 
was remarkably similar in both ambulatory recordings (Fig. 
1). Autocorrelation revealed significant positive first-order 
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Figure 1. Diurnal variation of ventricular premature beats (VPBs) 
for pooled data of 45 patients. Ordinate represents deviation of 
hourly arrhythmia from day's mean. Open circles and solid line = 
day 1; stars and dashed line = day 2. . 
autocorrelation coefficients in 49 (54%) of the 90 recordings. 
Higher order coefficients in the 90 recordings were less 
frequently significant (second-order, 23 [26%]; third-order, 8 
[9%]; fourth-order, 4 [4%]; fifth-order, 2 [2%]). 
Heart rate exhibited a similar pattern that was consistent 
for both recordings (Fig. 2). The hourly medians of heart rate ~ 
and ventricular ectopic activity showed a significant corre-
lation for both days (day 1: r = 0.57 ± 0.14 [95% confidence 
limit], p = 0.0024; day 2: r = 0.68 ± 0.08, p = 0.0003). 
Analysis of individual Holter recordings by crosscorrelation 
of heart rate and ventricular ectopic activity revealed a mean 
zero-order cross-correlation coefficient of 0.54 for both days 
(range on day 1, -0.83 to 0.89; day 2, -0.55 to 0.90). 
Day-to-day variability of arrhythmia (Table 2). Group 
comparisons revealed good reproducibility between the two 
ambulatory recordings with correlation coefficients between 
0.76 and 0.84. By contrast, linear regression analysis of 
individual data showed substantial day-to-day variability of 
ventricular ectopic activity (Fig. 3). Based on the 95% 
confidence limits, the minimal decrease in arrhythmia den~ 
sity required to identify a true drug effect ranged from 63.5% 
for single ventricular premature beats to 92.6% for ventric-
ular tachycardia beats (Table 2A). When the percentage of 
monitoring hours containing couplets or ventricular tachy-
cardia was used to define efficacy, less arrhythmia reduction 
was necessary to exclude spontaneous variability. An in-
crease ranging from 400% (single ventricular ectopic beats) 
to 2,400% (ventricular tachycardia beats) density was nec-
essary to distinguish spontaneous variability from genuine 
arrhythmia enhancement (Table 2B). 
Relation between clinical variables and day-to-day variabil-
ity of arrhythmias (table 3). To assess the influence of 
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Figure 2. Diurnal variation of heart rate in 45 patients. Symbols as in 
Figure 1. 
clinical variables on spontaneous variability, age, sex, un-
derlying heart disease, presenting arrhythmia, baseline 
arrhythmia density and left ventricular function were corre-
lated with the coefficients of variation of various arrhythmia 
categories. Stepwise regression analysis disclosed an inverse 
relation between the coefficient of variation and both the 
baseline arrhythmia density and age. The presence of coro-
nary artery disease was associated with more marked day-
to-day variability of single ventricular premature beats and 
ventricular tachycardia beats whereas left ventricular func-
tion and the type of presenting arrhythmia exerted no 
independent influence on spontaneous variability. 
Discussion 
Day-to-day variation and criteria for a drug effect. Several 
previous investigations (1,2,4,5,10-13) have documented 
that ventricular arrhythmias occur with substantial, seem-
ingly random variations. The general applicability of these 
results is uncertain, however, because they were obtained 
mainly in patients with benign arrhythmias not requiring 
therapy and because of differences in arrhythmia frequency 
and study design. Furthermore, many of these studies were 
limited by their focus on arrhythmia suppression without 
addressing the possibility of proarrhythmic effects. The 
present investigation shows that the day-to-day reproducibil-
ity of arrhythmias in patients with a history of life threaten-
ing arrhythmias and high density of ventricular ectopic 
activity on ambulatory EeG monitoring is good when group 
data are compared (Table 1). By contrast, when the effect of 
an intervention is evaluated in individuals, comparisons 
must allow for the considerable day-to-day variability found 
in these patients. The minimal suppression of arrhythmia 
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Table 2. Day-to-Day Variability of Ventricular Arrhythmia 
Minimum % 
Decrease (median) Range 
25th 
Percentile 
75th 
Percentile 
A. Criteria for True Drug Effect Based on 95% Confidence Limits 
.--~ -.-~-- - -,---_. 
Single VPBs 65.0 45.8 to 74.4 57.5 69.9 
Couplets 84.0 68.7 to 92.7 78.6 87.8 
Couplet hours 29.3 29.3 to 46.3 29.3 30.3 
VT beats 93.5 77.9 to 98.5 91.2 96.7 
VT episodes 89.8 79.1 to 96.5 97.2 93.8 
VT hours 70.0 53.5 to 100.00 53.5 97.9 
--- -~--.~~---
.. ~----
B. Criteria for Arrhythmia Aggravation Based on 95% Confidence Limits 
Single VPBs 415 
Couplets 877 
Couplet hours 231 
VT beats 2,394 
VT episodes 1,506 
VT hours 270 
Abbreviations as in Table 1. 
required for a true drug effect in this high risk population is 
comparable with that of patients with less serious ventricular 
arrhythmias. However, as a consequence of the nonlinear 
relation between baseline ventricular tachycardia density 
and minimal arrhythmia suppression, comparatively less 
reduction is necessary for <300 ventricular tachycardia 
episodes on day 1 (Fig. 4). A similar finding was reported by 
Pratt et al. (3). 
When one uses the percentage of hours containing cou-
plets of ventricular tachycardia instead of the hourly 
arrhythmia counts, the criteria for a drug effect are less 
stringent (Table 2A). For example, although the number of 
Figure 3. Linear regression analysis of day-to-day variability of 
ventricular tachycardia (VT) runs on day 1 and day 2 and two-tailed 
95% confidence limits. 
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hourly ventricular tachycardia episodes needs to be reduced 
by 89.5% to demonstrate efficacy, the percentage of hours 
containing ventricular tachycardia episodes has to decrease 
by only 70%. However, it is not clear whether this decrease 
is helpful because the reduction may be more difficult to 
achieve. 
Criteria for aggravation. The expanding armamentarium 
of powerful antiarrhythmic agents and the increasing number 
of patients with serious ventricular arrhythmias coming to 
treatment has heightened awareness of drug induced aggra-
vation of arrhythmia (14). To date, the criteria used to define 
this complication have often been arbitrary (6,14). Our 
investigation uses a statistical approach and establishes 
confidence limits for various categories of ventricular ecto-
pic activity (Table 2B). It is important to note that the 
minimal increase defining aggravation declines sharply as the 
density of ventricular tachycardia increases, remaining es-
sentially flat for> 300 ventricular tachycardia episodes per 
24 h on day 1 (Fig. 5). Furthermore, a minimum of 35 
episodes per 24 h must be present on day 2 to permit reliable 
detection of arrhythmia aggravation (Fig. 3). Therefore, to 
the extent that it is based on the frequency of ventricular 
Table 3. Factors Related to Spontaneous Variability of Malignant 
Ventricular Arrhythmias in 45 Patients 
Single VPBs Couplets VT Beats VT Episodes 
VEA Density -0.0001 -0.0002 -0.0001 -0.0001 
Age -0.0782 NS -0.0008 -0.031 
CAD 0.0376 NS 0.0948 NS 
Male gender -0.021 NS NS NS 
Heart rate NS 0.0141 NS NS 
CAD = coronary artery disease; VEA = ventricular ectopic activity: 
other abbreviations as in Table I. 
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Figure 4. Minimal arrhythmia suppression as a function of ventric-
ular tachycardia (VT) prevalence at baseline. Note that at higher 
ventricular tachycardia frequencies, the required reduction of 
ectopic activity levels off at approximately 96%. 
tachycardia episodes, the incidence of arrhythmia aggrava-
tion may have to be reassessed to reflect these constraints. 
Difference between clinical subsets. Pratt et a1. (3) recently 
reported that the spontaneous variability of arrhythmias 
differs among certain clinical subsets of patients. Those with 
coronary artery disease exhibited significantly greater vari-
ability of ventricular premature beats than patients without 
coronary artery disease whereas left ventricular function did 
not appear to influence variability. Although our results 
agree with these findings, they contrast with regard to 
baseline arrhythmia density. Multivariate regression analy-
sis disclosed an inverse relation between ventricular ectopic 
activity during day 1 and each of the arrhythmia categories 
analyzed. In addition, arrhythmia variability decreased with 
age and was more pronounced in female patients (Table 3). 
Table 4. Criteria for Drug Efficacy and Arrhythmia Aggravation 
Baseline 
No. 
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Figure 5. Minimal increase in ventricular tachycardia (VT) density 
as a function of ventricular tachycardia prevalence at baseline. With 
> 100 ventricular tachycardia events at baseline, the necessary 
increase in arrhythmia density is approximately tenfold. 
Circadian variation. There are conflicting reports con-
cerning the diurnal distribution of ventricular ectopic activ-
ity. Although some authors found no relation between ecto-
pic activity and sleep-wake cycles (4,15-17) or an increase 
during sleep (18,19), our observations as well as those of 
others (2,20-23) demonstrate the presence of circadian peri-
odicity. This finding is even more persuasive in light of the 
remarkably similar pattern evident during the two monitor-
ing periods. Autocorrelation analysis of individual record-
ings disclosed significant first-order coefficients in 54% of 
recordings. This indicates that the arrhythmia density of a 
given hour influences the succeeding or even later hours, 
reflecting a waxing and waning of arrhythmogenesis. The 
mechanisms underlying the described diurnal variations re-
main largely unexplored. Fluctuations in sympathetic or 
Minimal Reduction (%) Minimal Increase (%) 
AuthorlReference ofPts Interval (days) VPBs/h Couplets/h VTIh VPBs Couplets VT VPBs Couplets VT 
Morganroth et al. (4) 15 37 to 1,801 83 
Michelson and 20 >30 20/20 pts 14/20 pts 75 65 
Morganroth (2) 
Sami et al. (I) 21 14 48 0.2* 65 85* 
Morganroth and 3 to 10 = fold 
Horowitz et aL (6) 
Pratt et aI. (3) 110 663 43 19 78 83 77 
Pratt et al. (II) 26 17 months 580 20 50t 65t 83t 
Pratt et aL (5) 88 8 103 1.9 7.1 95 88 1,780 217 
Toivonen (10) 20 4 days to 9 777 44* 65 to 100 78 to >I()()* 
months 
*Repetitive VPBs; tobserved spontaneous reduction; Pts = patients. Other abbreviations as in Table I. 
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parasympathetic tone are possibly involved as suggested by 
the circadian pattern of heart rate. This mechanism is also 
suggested by a recent report by Zimmermann et al. (24) who 
found a positive correlation between the heart rate preceding 
an episode of ventricular tachycardia and its length. They 
interpreted this correlation as adrenergic dependence. More 
research is needed to clarify the role of the autonomic 
nervous system in spontaneous ventricular arrhythmia. 
Regardless of the mechanisms, recent observations on 
the diurnal distribution of in-hospital cardiorespiratory ar-
rest (25) and out of hospital sudden cardiac death (26) 
provide an intriguing correlate to our findings. Eltringham 
and Dobson (25) reviewed the records of 218 patients with 
in-hospital cardiac arrest and noted two peak periods (13:00 
to 15:00 hand 18:00 to 21:00 h) during which 34% of all 
incidents occurred. Muller et al. (26) surveyed all cases of 
sudden cardiac death reported in Massachusetts for the year 
1983 and found a preponderance of events in the late 
morning hours with a peak just before noon. At present, it is 
not entirely clear whether these observations represent a 
true diurnal pattern or whether confounding factors such as 
selection bias playa role. 
Conclusions. Our study demonstrates that patients with a 
high density of malignant arrhythmias exhibit substantial 
day-to-day variability. Therefore, confidence limits must be 
observed in assessing the effect of therapeutic interventions. 
There appears to be a circadian pattern of ventricular ectopic 
activity that correlates well with heart rate. The mechanism 
of diurnal fluctuations and the potential role of the auto-
nomic nervous system require further investigation. 
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